Actively Recruiting
Development of a Risk Stratification Score for Recurrent Venous Thromboembolism and Treatment-related Clinically Relevant Bleeding in Patients With Cancer-associated Thrombosis
Led by Ottawa Hospital Research Institute · Updated on 2025-03-25
1000
Participants Needed
1
Research Sites
156 weeks
Total Duration
On this page
Sponsors
O
Ottawa Hospital Research Institute
Lead Sponsor
C
Canadian Institutes of Health Research (CIHR)
Collaborating Sponsor
AI-Summary
What this Trial Is About
The objective of this study is to prospectively develop a risk assessment model (RAM) that accurately identifies anticoagulated cancer-associated thrombosis (CAT) patients at low- and high-risk of recurrent venous thromboembolism (VTE) and clinically relevant bleeding within 6 months following the CAT diagnosis and to create a biobank of plasma and whole blood samples for further translational research in cancer genetics and hemostasis.
CONDITIONS
Official Title
Development of a Risk Stratification Score for Recurrent Venous Thromboembolism and Treatment-related Clinically Relevant Bleeding in Patients With Cancer-associated Thrombosis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Objectively documented distal and/or proximal deep vein thrombosis (DVT) of the limb (upper or lower extremity) and/or pulmonary embolism (PE), splanchnic vein thrombosis and/or cerebral sinus vein thrombosis with active cancer of any type
- Planned anticoagulant treatment for cancer-associated thrombosis for at least 6 months at therapeutic dosing
- Estimated life expectancy greater than 6 months
- Willingness to provide informed consent
- Age 18 years or older
You will not qualify if you...
- Unusual site cancer-associated thrombosis such as gonadal vein thrombosis, ovarian vein thrombosis, or retinal vein thrombosis
- Superficial vein thrombosis
- Refusal to give informed consent more than 72 hours after starting anticoagulants
- Age under 18 years old
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Ottawa Hospital Research Institute
Ottawa, Ontario, Canada, K1H8L6
Actively Recruiting
Research Team
K
Kristina Vrotniakaite-Bajerciene, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here